You are here

Optimi Health Corp.

Optimi Health Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
OPTI
CSE Index: 
Currency: 

Optimi Health is a homegrown, Canadian success story producing and supplying natural, GMP-grade psilocybin and functional mushrooms that focus on the health and wellness markets. Built with the purpose to produce scalable, natural mushroom formulations for transformational human experiences, our goal is to be the number one trusted, compassionate supplier of safe, natural GMP-grade psilocybin across the world. With a vertically integrated approach, Optimi intends to cultivate, extract, process and distribute high quality functional and psychedelic mushroom products at its two facilities comprising a total of 20,000 square feet in Princeton, British Columbia. 

To fully investigate the science of mushrooms, the Company has received a research exemption under Health Canada Food and Drug Regulations (FDR) for the use of Psilocybin and Psilocin for scientific purposes via its wholly owned subsidiary Optimi Labs Inc. Optimi has also been granted a dealer’s license under Canada’s Narcotic Control Regulations governing possession, distribution, sale, laboratory analysis of and research and development of Psilocybin and Psilocin formulations. Optimi is committed to expert cultivation and quality production subject to and in accordance with the terms of all applicable laws and governing regulations to ensure safe, superior Canadian fungi production. 

You are here

Optimi Health Corp. (OPTI)

SEDAR Information

Company Info

Address
330 – 1122 Mainland Street
Vancouver, BC V6B 5L1
Canada
Phone
778-761-4551
Email
investors@optimihealth.ca
Website
http://www.optimihealth.ca
Listing date
Tuesday, February 23, 2021
Transfer Agent
Endeavor Trust Corporation
Investor Relations
Kidder Management Group Inc.
Email
investors@optimihealth.ca
Auditor
Smythe LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
70,231,883
Reserved for Issuance: 
48,613,005

Company Officers

Bill Ciprick, Chief Executive Officer
Bryan Safarik, Chief Operating Officer
Dane Stevens, Chief Marketing Officer
Jacob Safarik, Chief Financial Officer
Leah Hodges, Corporate Secretary

Bulletins

23/02/2021

2021-0244 – New Listing - Optimi Health Corp. (OPTI, OPTI.WT)

Le 23 février/February 2021

The common shares and warrants of Optimi Health Corp. have been approved for listing on the CSE.

Each warrant shall entitle each warrantholder thereof, upon exercise at any time after the Issue Date and before the Expiry Time, to acquire one Common Share upon payment of the Exercise Price of $1.25.

Advertisement

Publicité

Latest CSE News

Upcoming Events

Website_2.jpg

Capital Markets Comeback Tour

Wednesday, May 11, 2022 to Thursday, June 2, 2022